Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-{kappa}B Activation

This study represents the first evidence that combination therapy with balsalazide and parthenolide could be a new regimen for colorectal cancer treatment. Mol Cancer Res; 15(2); 141–51. ©2016 AACR.

Source: Molecular Cancer Research - January 30, 2017 Category: Cancer & Oncology Authors: Kim, S.-L., Kim, S. H., Park, Y. R., Liu, Y.-C., Kim, E.-M., Jeong, H.-J., Kim, Y. N., Seo, S. Y., Kim, I. H., Lee, S. O., Lee, S. T., Kim, S.-W. Tags: Cell Death and Survival Source Type: research